Zimmer Biomet Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Zimmer Biomet (ZBH) PT Raised to $197 at Baird
August 4, 2021 9:02 AM EDTBaird analyst Jeffrey Johnson raised the price target on Zimmer Biomet (NYSE: ZBH) to $197.00 (from $195.00) while maintaining an Outperform rating.
The analyst commented, "A few issues weighed on shares yesterday, including China tender and ZBH market share uncertainties and somewhat sluggish pace of... More
Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 3c
August 3, 2021 6:35 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $1.90, $0.03 better than the analyst estimate of $1.87. Revenue for the quarter came in at $2.03 billion versus the consensus estimate of $1.98 billion.
"Our performance in the second quarter improved meaningfully from the first quarter 2021 across all... More
